GlaxoSmithKline plc (LON:GSK) had its price target raised by analysts at Deutsche Bank AG from GBX 1,700 ($21.51) to GBX 1,720 ($21.76) in a note issued to investors on Friday, May 12th. The brokerage currently has a “hold” rating on the stock. Deutsche Bank AG’s target price points to a potential upside of 2.08% from the company’s current price.
GSK has been the subject of a number of other reports. BNP Paribas reissued an “underperform” rating and set a GBX 1,520 ($19.23) target price on shares of GlaxoSmithKline plc in a research note on Sunday, January 15th. Jefferies Group LLC increased their target price on GlaxoSmithKline plc from GBX 1,780 ($22.52) to GBX 1,800 ($22.77) and gave the stock a “buy” rating in a research note on Friday, February 17th. Shore Capital reissued a “hold” rating on shares of GlaxoSmithKline plc in a research note on Thursday, January 12th. Beaufort Securities reissued a “buy” rating and set a GBX 1,750 ($22.14) target price on shares of GlaxoSmithKline plc in a research note on Thursday, February 16th. Finally, Goldman Sachs Group, Inc. (The) increased their target price on GlaxoSmithKline plc from GBX 1,800 ($22.77) to GBX 1,850 ($23.40) and gave the stock a “buy” rating in a research note on Tuesday, January 24th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have assigned a buy rating to the company. GlaxoSmithKline plc currently has an average rating of “Hold” and a consensus price target of GBX 1,745.17 ($22.08).
GlaxoSmithKline plc (GSK) traded up 0.06% during midday trading on Friday, hitting GBX 1685.00. The company’s stock had a trading volume of 19,969,256 shares. GlaxoSmithKline plc has a one year low of GBX 1,363.00 and a one year high of GBX 1,745.56. The company’s 50-day moving average is GBX 1,647.07 and its 200 day moving average is GBX 1,604.10. The company’s market cap is GBX 82.33 billion.
The company also recently announced a dividend, which will be paid on Thursday, July 13th. Investors of record on Thursday, May 11th will be given a GBX 19 ($0.24) dividend. This represents a dividend yield of 1.21%. The ex-dividend date of this dividend is Thursday, May 11th.
In other news, insider Emma Walmsley bought 83 shares of the business’s stock in a transaction that occurred on Tuesday, April 18th. The shares were acquired at an average cost of GBX 1,647 ($20.83) per share, with a total value of £1,367.01 ($1,729.30). Also, insider Vivienne Cox bought 335 shares of the business’s stock in a transaction that occurred on Wednesday, April 26th. The stock was purchased at an average cost of GBX 1,583 ($20.03) per share, for a total transaction of £5,303.05 ($6,708.48). Insiders purchased a total of 662 shares of company stock worth $1,067,188 over the last ninety days.
GlaxoSmithKline plc Company Profile
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.